Abstract-Liver microsomal 0-dealkylation activity was determined using 0-methyl, 0-ethyl and 0-propyl derivatives of p-nitrophenol, 7-hydroxycoumarin (umbelliferon) and 7-hydroxyphenoxazone (resorufin) as substrates. Microsomal 0-dealkylation activities of p-nitrophenol and 7-hydroxycoumarin 0-alkyl derivatives were of similar levels, but the activities of 7-hydroxyphenoxazone O-alkyl derivatives were very low compared with those of other substrates. Pretreatment of rats with (9-naphthoflavone resulted in the preferential increase of 0-deethylation and 0-depropylation activities regardless of the ring structure of the substrates, and the ratio of 0-deethylation and 0-depropylation activities to that of 0-demethylation increased markedly. On the other hand, the 0-dealkylase activity of all substrates increased generally upon pretreatment of the rats with phenobarbital, but the ratio of 0-deethylase or 0-depropylase activity to that of 0-demethylase in the pretreated rats was not very different from that of the untreated animals. Hexobarbital inhibited competitively the 0-dealkylation activity in control and phenobarbital-pretreated rat microsomes. On the other hand, the 0-dealkylase activity
The hepatic microsomal cytochrome P-450 monooxygenase system functions in oxidative biotransformation of a wide variety of both endogenous and exogenous compounds (1 3) . Recent studies have established the existence of multiple forms of cytochrome P-450 in liver microsomes obtained from various species of animals (4) (5) (6) , and at tempts to establish the substrate specificity of each form of cytochrome P-450 have hitherto been carried out using purified cytochrome P-450 or liver microsomes pre pared from animals in various states (5) (6) (7) (8) .
The results indicate overlapping substrate specificities among various forms of the hemoprotein.
The O-dealkylation reaction of various compounds was widely employed as a measure of cytochrome P-450-dependent monooxygenase (9) (10) (11) (12) (13) (14) (15) . Recent studies have indicated a marked increase of the 0 dealkylase activity of 7-ethoxy and 7
propoxy-coumarins, but not of 7-methoxy coumarin, in liver microsomes obtained from 3-methylcholanthrene or 4-naphthoflavone pretreated rats or some forms of purified cytochrome P-450. On the other hand, pretreatment of rats with phenobarbital resulted in a marked increase in the specific activity of the 0-dealkylation reaction for all 0-alkyl derivatives of 7-hydroxycoumarin (umbelliferon) (11, (16) (17) (18) 
Materials and Methods
Animals and their treatments: Adult male rats of the Wistar strain, 9 to 11 weeks old, were used. The rats were kept in an air conditioned room (25±1 °C, 50-60% humidity) lighted 12 hr a day (8:00-20:00) and maintained on commercial rat chow (CA 1, Japan Clea, Tokyo) and water ad libitum. Also used were the following adult male animals: mice (ICR and C57BL/6J strains, 10-11 weeks old), rabbits (JW-NIBS/ Rabiton, 2.5-3.0 kg) and guinea pigs (Hartly, 300-350 g). They were kept under similar conditions. Some of the animals were intra peritoneally given phenobarbital in physio logical saline or Q-naphthoflavone in sesame oil once a day for 3 consecutive days at the dose of 40 mg/kg body weight. Non-fasted animals were decapitated one day after the last injection, and the livers were quickly removed. Rabbits were killed under ether anaethesia.
Liver microsomes were prepared as described previously (17). Based on these fluorescence properties of resorufin and its 0-alkyl derivatives, the fluorometric determination of resorufin pro duced in the reaction mixture during the incubation was performed at 583 nm with excitation at 550 nm to minimize the effect of excitation light-scattering. Under the fluorometric assay conditions employed, the relative fluorescence intensities of alkoxy resorufin and resorufin were 0.16 and 100, respectively.
Resorufin and its 0-alkyl derivatives in the complete reaction mixture were stable even after the addition of the PCA-glycine mixture, and the fluorescence spectra were not affected by this treatment. The recovery of resorufin was determined by adding various amounts of resorufin (0.60 10.0 pM) to the microsomal suspension, and the recovery ranged from 85-92%.
Synthesis of alkoxyresorufin (7-alkoxy phenoxazone):
The 0-methyl, 0-ethyl and 0-propyl derivatives of resorufin were syn thesized using the corresponding alkyl iodides essentially as for the synthesis of 7-alkoxy coumarin (17). Resorufin (2 g), alkyl iodide (25 g) and potassium hydroxide (1.0-1.2 g) in 270 ml methanol were incubated at 60 70'C for 6-12 hr. After evaporation of the methanol under reduced pressure, the prod ucts were dissolved in a dichloromethane H20 mixture (10:2-3, v/v), and the dichloro methane phase was washed several times with 1 % (w/v) KOH until the aqueous phase was clear. Next, the solvent was evaporated, and the products were dissolved in a propoxyresorufin, but only a slight or no effect on the O-deethylation or 0-demethy lation activity, respectively. Administration of E3-naphthoflavone caused an increase in the O-dealkylation activity of 7-alkoxyresorufin, and the increase in the 0-deethylation and 0 depropylation activities was much more prominent than the 0-demethylation activity ( Table 1) . The results shown in Table 1 Effect of hexobarbital and a-naphtho flavone on microsomal 0-dealkylase system: The in vitro effects of hexobarbital and a naphthoflavone were studied to clarify the correlation between substrate specificity of the 0-dealkylation reaction and the molecular form of cytochrome P-450, employing the 7-alkoxycoumarin 0-dealkylation reaction as a model. Addition of typical type I compound, hexobarbital (26), to the incubation mixture for the 0-dealkylase assay resulted in inhi bition of the microsomal 0-dealkylation activity in untreated (intact) and pheno barbital-pretreated rats, while the activity in a-naphthoflavone-pretreated rats was affected only slightly by higher concentrations (3.33 mM or more) of hexobarbital (Fig. 2) . The inhibitory pattern of hexobarbital was further examined by adding various concen trations of the compound to the incubation mixture. As shown in Fla. 3, higher 0 dealkylation activity was obtained by adding more substrate, and the activity was de pressed gradually by the addition of increased concentrations of hexobarbital. The Dixon plot (Fig. 3, inset) clearly shows that the 0 dealkylation activity was inhibited compe titively by hexobarbital. The inhibitory pattern of hexobarbital was the same regardless of the microsomal species and 0-alkyl group sub stitution of the substrate. The inhibition constants (K;) of hexobarbital thus obtained are summarized in Table 2 . The constant calculated for untreated rat liver microsomes increased following elongation of the alkyl chain length of the substrate, and no differ ence in the values was observed when liver microsomes prepared from untreated and phenobarbital-pretreated rats were used. On the other hand, the inhibition constants obtained for i9-naphthoflavone-pretreated rat microsomes were quite different from the others and very high values were observed ( Table 2) .
The effect of a-naphthoflavone, a specific inhibitor of microsomal cytochrome P-448 dependent hydroxylation reactions (27), upon microsomal 7-alkoxycoumarin 0-dealkylase was also determined. As shown in Fig. 4 , the 0-dealkylation activity in liver microsomes obtained from i3-naphthoflavone-pretreated rats was inhibited remarkably by a-naphtho flavone, and the inhibitory pattern was a competitive one (data not shown). On the contrary, the 0-dealkylase activity in un treated and phenobarbital-pretreated rats was not inhibited by a-naphthoflavone.
The inhi bition constants of a-naphthoflavone for in hibition of the 0-dealkylation reaction in ,3 naphthoflavone-pretreated rat liver micro somes are shown in Table 2 , which shows that the lowest inhibition constant appeared in the 0-depropylation reaction. Comparison of 7-alkoxycoumarin 0 dealkylation activity among various species of animals: Marked species differences in the metabolism of drugs have become evident during the past two decades (28). Thus, the 0-dealkylation activity has been studied using liver microsomes obtained from various species of animals. As observed in rat liver microsomes (Table 1 ) , changing the alkyl group of the substrate from a methyl to a propyl group resulted in marked alteration in the 0-dealkylation activities in all microsomes tested.
When microsomes obtained from untreated animals were employed, the 0 demethylation activity was generally the highest and 0-depropylation activity the lowest (Table 3) , although little or no difference was found between them in rat liver microsomes. Administration of pheno barbital caused increases in cytochrome P Fig. 4 . Effect of a-naphthoflavone on microsomal 7-alkoxycoumarin 0-dealkylase. Microsomal 0 dealkylase activity was determined as described in the legend of Fig. 2 , using a-naphthoflavone as the inhibitor instead of hexobarbital. Concentrations of a-naphthoflavone added were 4.9 and 49.0 uM. Microsomal concentrations in intact (untreated), phenobarbital (PB)-pretreated and j3-naphtho flavone ((3-NF)-pretreated rats were 1.36, 1.03 and 1.33 mg protein/ml of incubation mixture, respectively. Table 3 . Effect of pretreatment of animals with phenobarbital and (3-naphthoflavone on liver microsomal 7-alkoxycoumarin 0-dealkylase in various adult male animals
The animals were administered intraperitoneally phenobarbital (PB) or t3-naphthoflavone (j3-NF) at the dose of 40 mg/kg for 3 days. Mouse liver micro somes were prepared using pooled livers from 3-4 animals, and the number of microsomal preparations is in parenthesis.
The values in the of rabbits with (3-naphthoflavone resulted in a marked increase in cytochrome P-450 (P-448) content, but the 0-dealkylase activity was not affected. Under the experi mental conditions employed, the 0-dealkylase activity and the cytochrome content in guinea pigs and the ICR strain of mice were not altered by the administration of (3 naphthoflavone ( Table 3) . The results shown in Table 3 suggest marked species and strain differences in the composition of cytochrome P-450 isozyme in microsomal membrane and in the inducibility of the cytochrome P-450 (Fig. 4) . When the 0-dealkylase activities in (3 naphthoflavone-pretreated rats were deter mined in the presence of rabbit antibodies against the phenobarbital-induced form (P 450PB) and the 3-methylcholanthrene inducible form (P-450Nc) of rat liver micro somal cytochrome P-450, both 0-de ethylation and 0-depropylation activities were depressed preferentially by the antibody against P-450,,1,, but the antibody against P-450p,, did not affect the activities (un published results). These results also support that cytochrome P-448 preferentially catalyzes the 0-deethylation and 0-de propylation reactions of 7-alkoxycoumarin. Administration of phenobarbital resulted in increase of microsomal 0-dealkylation ac tivity for all substrates, but no remarkable alteration in the substrate specificity like that observed in the cytochrome P-448-dependent reaction was obtained by phenobarbital treatment (Table 1) . Competitive inhibition of the microsomal 0-dealkylation reaction by hexobarbital (Figs. 2 and 3) indicates that some forms of cytochrome P-450 interact specifically with hexobarbital and 7-alkoxy coumarin, and these chemicals compete for the same binding site on the hemopro tein(s). Interestingly, the inhibition constant for hexobarbital inhibition in phenobarbital pretreated rats was almost the same as that in control rats (Table 2) , suggesting also that the phenobarbital-inducible form(s) of cyto chrome P-450 has similar substrate specificity S. OTSUBO & E. YOSHIHARA to that of the constitutive form (s) of the cytochrome with respect to the 0-dealky lation reaction of 7-alkoxycoumarin. Addition of antibody against P-450PB, but not P 450,,c, to the incubation mixture for the 0 dealkylase assay caused the inhibition of the activity in phenobarbital-pretreated rats (unpublished results). The results also support the participation of phenobarbital-inducible form(s) of cytochrome P-450's in the in creased 0-dealkylation activity of the pretreated rats. Clarification of the relation ship between every isozyme of purified cytochrome P-450 and substrate specificity in the 0-dealkylation reaction remains a subject for further study.
Species and strain differences in drug metabolism are well established, and quali tative or quantitative differences are observed depending upon the drugs employed. The differences were also detected in the case of the 0-dealkylation reaction of 7-alkoxy coumarin ( Table 3) . Pretreatment of animals with phenobarbital caused increases in cytochrome P-450 content and in the 0 dealkylation activity in all animals tested. On the other hand, species differences in the inducibility of the microsomal 0-dealkylase system by i3-naphthoflavone were obtained; a marked increase in the 0-dealkylase system upon pretreatment of the animals with 8 naphthoflavone was observed only in rats and C57BL/6J strain mice. Interestingly, adminis tration of (3-naphthoflavone to rabbits caused a marked increase of cytochrome P-450 (P-448) content, but the O-dealkylation activity was not influenced ( Table 3) . The results agree with the report of Levine et al.
(30) that little or no catalytic activity of benzo (a) pyrene hydroxylation occurs with 3 methylcholanthrene-induced rabbit liver cytochrome P-448. Inducibility of microsomal 0-dealkylase in various species of animals by (3-naphthoflavone (Table 3 ) may be cor related with the Ah locus characteristics (27, 31) , and then the relationship should be clarified between species differences in the 0-dealkylation reaction and molecular species of cytochrome P-450 in different animals. 
